https://orcid.org/0000-0003-4268-1468
References
- Voysey M, Clemens SAC, Madhi SA, et al. Oxford COVID Vaccine Trial Group. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 Jan 9;397(10269):99–111. doi:https://doi.org/10.1016/S0140-6736(2032661-1. Erratum in: Lancet. 2021;397(10269):98.
- COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks – update. https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-prac-investigating-cases-thromboembolic-events-vaccines-benefits. Accessed April 18, 2021.
- Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 Apr 9;384(22):2092–2101. doi:https://doi.org/10.1056/NEJMoa2104840. Epub ahead of print.
- Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021 Apr 9;384(22):2124–2130. doi:https://doi.org/10.1056/NEJMoa2104882. Epub ahead of print.
- Bhavsar KV, Lin S, Rahimy E, et al. Acute macular neuroretinopathy: a comprehensive review of the literature. Surv Ophthalmol. 2016;61(5):538–565. doi:https://doi.org/10.1016/j.survophthal.2016.03.003.
- Casalino G, Arrigo A, Romano F, Munk MR, Bandello F, Parodi MB. Acute macular neuroretinopathy: pathogenetic insights from optical coherence tomography angiography. Br J Ophthalmol. 2019;103(3):410–414. doi:https://doi.org/10.1136/bjophthalmol-2018-312197.
- Gascon P, Briantais A, Bertrand E, et al. Covid-19-associated retinopathy: a case report. Ocul Immunol Inflamm. 2020;28(8):1293–1297. doi:https://doi.org/10.1080/09273948.2020.1825751.
- Zamani G, Ataei Azimi S, Aminizadeh A, et al. Acute macular neuroretinopathy in a patient with acute myeloid leukemia and deceased by COVID-19: a case report. J Ophthalmic Inflamm Infect. 2021;10(1):39. doi:https://doi.org/10.1186/s12348-020-00231-1.
- Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond). 2020;34(12):2352–2353. doi:https://doi.org/10.1038/s41433-020-1069-8.
- Plu-Bureau G, Hugon-Rodin J, Maitrot-Mantelet L, Canonico M. Hormonal contraceptives and arterial disease: an epidemiological update. Best Pract Res Clin Endocrinol Metab. 2013;27(1):35–45. doi:https://doi.org/10.1016/j.beem.2012.11.003.
- Peragallo Urrutia R, Coeytaux RR, McBroom AJ, et al. Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis. Obstet Gynecol. 2013;122(2 Pt 1):380–389.doi:https://doi.org/10.1097/AOG.0b013e3182994c43.
- Liu JC, Nesper PL, Fawzi AA, Gill MK. Acute macular neuroretinopathy associated with influenza vaccination with decreased flow at the deep capillary plexus on OCT angiography. Am J Ophthalmol Case Rep. 2018;10:96–100. doi:https://doi.org/10.1016/j.ajoc.2018.02.008.
- Shah P, Zaveri JS, Haddock LJ. Acute macular neuroretinopathy following the administration of an influenza vaccination. Ophthalmic Surg Lasers Imaging Retina. 2018;49(10):e165–e168. doi:https://doi.org/10.3928/23258160-20181002-23.
- Devin F, Roques G, Disdier P, Rodor F, Weiller PJ. Occlusion of central retinal vein after hepatitis B vaccination. Lancet. 1996;347(9015):1626. doi:https://doi.org/10.1016/s0140-6736(96)91112-5.
- Granel B, Disdier P, Devin F, et al. Occlusion de la veine centrale de la rétine après vaccination contre l’hépatite virale B par vaccin recombinant. Quatre observations [Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases]. Presse Med. 1997: 26(2): 62–65. French
- Chen X, Rahimy E, Sergott RC, et al. Spectrum of retinal vascular diseases associated with paracentral acute middle maculopathy. Am J Ophthalmol. 2015;160(1):26–34.e1. doi:https://doi.org/10.1016/j.ajo.2015.04.004.
- Moysidis SN, Koulisis N, Patel VR, et al. The second blind spot: small retinal vessel vasculopathy after vaccination against neisseria meningitidis and yellow fever. Retin Cases Brief Rep 2017 Winter;11(Suppl 1);S18–S23. doi:https://doi.org/10.1097/ICB.0000000000000391.
- McKay BR, Ta Kim D, Wong DT. Paracentral acute middle maculopathy after meningococcal vaccination in a young female. Can J Ophthalmol. 2020;55(6):e192–e195. doi:https://doi.org/10.1016/j.jcjo.2020.06.024.
- Posthouwer D, Voorbij HA, Grobbee DE, Numans ME, van der Bom JG. Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation. Vaccine. 2004;23(3):362–365. doi:https://doi.org/10.1016/j.vaccine.2004.05.035.
- Liuba P, Aburawi EH, Pesonen E, et al. Residual adverse changes in arterial endothelial function and LDL oxidation after a mild systemic inflammation induced by influenza vaccination. Ann Med. 2007;39(5):392–399. doi:https://doi.org/10.1080/07853890701390111.
- European center for disease prevention and control COVID-19 vaccine tracker https://qap.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html Accessed April 18, 2021.